More than 900 Patients Benefit with Heberprot-P in Las Tunas
Las Tunas, Cuba.- Some 936 patients from this eastern province benefited with the application of Heberprot-P, through the comprehensive program for the detection and treatment of diabetic foot ulcers (DFU).
Over 220,000 Patients in the World Benefited from Heberprot-P
Havana.- More than 220,000 patients in 30 countries benefit from the use of the Cuban medicine Heberprot-P, unique of its kind and marketed by Cuba, which reduces the rate of diabetic foot amputation.
Heberprot-P Treatment Reaches Patients in Rural Communities
Las Tunas.- The Alberto Arcos Luque polyclinic in Bartle – a community located some 23 kilometers from Las Tunas city- stands out for the inclusion of patients for treatment with Heberprot-P, a Cuban product, which accelerates the healing of diabetic foot ulcers.










